Skip to content
OpenCapital
Get started

First Tracks Biotherapeutics, Inc. Ordinary Shares TRAX Cash Flow Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26
Net income
-$50.48M-7.0%
Depreciation and amortization
$125K-14.4%
Stock-based compensation
$11.5M+48.5%
Net cash from operating activities
-$32.56M+27.7%
Capital expenditures
$17K-51.4%
Net cash from investing activities
$34.98M+136%
Net cash from financing activities
$7.85M+37.4%
Net increase (decrease) in cash
$10.27M+142%
Free cash flow
-$32.58M+27.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does First Tracks Biotherapeutics, Inc. Ordinary Shares's cash flow data come from?
Every line is extracted from First Tracks Biotherapeutics, Inc. Ordinary Shares's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.